Health-related Quality of Life and Virologic outcomes in an HIV Clinic
Cite this article as: Call, S., Klapow, J., Stewart, K. et al. Qual Life Res (2000) 9: 977. doi:10.1023/A:1016668802328 Abstract Objective: The purpose of this study was to describe the relationship between viral load and health-related quality of life (HRQOL) in a cohort of persons with human immunodeficiency virus (HIV) infection. Design: We evaluated HRQOL measurements in a clinical cohort of HIV-positive patients recruited from a university-associated HIV primary care clinic. HRQOL instruments included the medical outcomes survey-short form-36(MOS-SF-36) from which mental and physical component summary scores (MCS and PCS) and subscale scores were calculated. Results: Significant negative associations were found between viral load and SF-36 PCS, physical functioning (PF), role-physical (RP), bodily pain (BP), general health (GH), role-emotional (RE), and vitality (VT). Similar negative associations were found between CD4 cell count and SF-36 summary and subscale scores, with the notable exception of bodily pain. Multivariate analyses controlling for the effects of CD4 cell count and other clinical variables indicated viral load as an independent predictor of SF-36 PCS, RP, BP and VT scores. Conclusions: The relationship between viral load, a measure of HIV disease activity, and several dimensions of the SF-36, a patient-focused measure of HRQOL, appears to be strong and independent of CD4 cell count. These findings suggest that having a lower viral load positively impacts the quality of life of HIV-positive patients. AIDS Health-related quality of life HIV SF-36
This revised version was published online in July 2006 with corrections to the Cover Date.
Coombs RW, Welles SL, Hooper C, et al. Association of plasma human immunodeficiency virus type 1 RNA level with risk of clinical progression in patients with advanced infection. J Infect Dis 1996; 174: 704–712.
Gulick RM. Current antiretroviral therapy: An overview. Qual Life Res 1997; 6: 471–474.
Hughes MD, Johnson VA, Hirsch MS, et al. Monitoring plasma HIV-1 RNA levels in addition to CD4 lymphocyte count improves assessment of antiretroviral therapeutic response. Ann Intern Med 1997; 126: 929–938.
Mellors JW, Rinaldo CR, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996; 272: 1167–1170.
Mellors JW, Munoz A, Giorgi JV, et al. Plasma viral load and CD4 lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997; 126: 946–954.
O'Brien WA, Hartigen PM, Martin D, et al. Changes in plasma HIV-1 RNA and CD4 lymphocyte counts and the risk of progression to AIDS. N Engl J Med 1996; 334: 426–431.
O'Brien WA, Hartigan PM, Daar ES, Simberkoff MS, Hamilton JD. Changes in plasma HIV RNA levels and CD4 lymphocyte counts predict both response to antiret-roviral therapy and therapeutic failure. Ann Intern Med 1997; 126: 939–945.
Anonymous. From the centers for disease control and prevention. Update: Trends in AIDS incidence - US, 1996. JAMA 1997; 278: 1485–1496.
Gulick RM, Mellors JW, Havlir D, et al. Treatment with indinavir, zidovudine and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N Engl J Med 1997; 337: 734–739.
Hammer SM, Squires KE, Hughes MD, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. N Engl J Med 1997; 337: 725–733.
Palella FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998; 338: 853–860.
Anderson JP, Kaplan RM, Coons SJ, Schneiderman LJ. Comparison of the quality of well-being scale and the SF-36 results among two samples of ill adults: AIDS and other illnesses. J Clin Epidemiol 1998; 51: 755–762.
O'Keefe E, Wood R. The impact of human immunodeficiency virus (HIV) infection on quality of life in a multiracial South African population. Qual Life Res 1996; 5: 275–280.
Smith MY, Feldman J, Kelly P, DeHovitz JA, Chirgwin K, Minkoff H. Health-related quality of life of HIV-infected women: Evidence for the reliability, validity and respon-siveness of the medical outcomes study short-form 20. Qual Life Res 1996; 5: 47–55.
Ryan CF, White JM. Health status at entry to methadone maintenance treatment using the SF-36 health survey questionnaire. Addiction 1996; 91: 39–45.
Holmes W, Bix B, Shea J. SF-20 score and item distribu-tions in a human immunodeficiency virus-seropositive sample. Med Care 1996; 34: 562–569.
Tsevat J, Solzan JG, Kuntz KM, et al. Health values of patients infected with human immunodeficiency virus. Relationship to mental health and physical functioning. Med Care 1996; 34: 44–57.
Hays RD, Shapiro MF. An overview of generic health-related quality of life measures for HIV research. Qual Life Res 1992; 1: 91–97.
Wu AW, Hays RD, Kelly S, Malitz F, Bozzette SA. Applications of the medical outcomes study health-related quality of life measures in HIV/AIDS. Qual Life Res 1997; 6: 531–554.
Wachtel T, Piette J, Mor V, Stein M, Fleishman J, Carpenter C. Quality of life in persons with human immuno-deficiency virus infection: Measurement by the medical outcomes study instrument. Ann Intern Med 1992; 116: 129–137.
Revicki DA, Wu AW, Murray MI. Change in clinical sta-tus, health status, and health utility outcomes in HIV-in-fected patients. Med Care 1995; 33: AS173–182.
Ragsdale D, Morrow JR. Quality of life as a function of HIV classification. Nurs Res 1990; 39: 355–359.
Bozzette SA, Hays RD, Berry SH, Kanouse DE, Wu AW. Derivation and properties of a brief health status assessment instrument for use in HIV disease. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 8: 253–265.
Williams JB, Rabkin JG. The concurrent validity of items in the quality-of-life index in a cohort of HIV-positive and HIV-negative gay men. Control Clin Trials 1991; 12: 129S–141S.
Hughes TE, Kaplan RM, Coons SJ, Draugalis JR, Johnson JA, Patterson TL. Construct validities of the quality of well-being scale and the MOS-HIV-34 health survey for HIV-infected patients. Med Decis Making 1997; 17: 439–446.
Kaplan RM, Patterson TL, Kerner DN, Atkinson JH, Heaton RK, Grant I. The quality of well-being scale in asymptomatic HIV-infected patients. HNRC group. HIV Neural Behavioral Research Center. Qual Life Res 1997; 6: 507–514.
Copfer AE, Ampel NM, Hughes TE, et al. The use of two measures of health-related quality of life in HIV-infected individuals: A cross-sectional comparison. Qual Life Res 1996; 5: 281–286.
Kaplan RM, Anderson JP, Patterson TL, et al. Validity of the quality of well-being scale for persons with human immunodeficiency virus infection. HNRC group. HIV Neurobehavioral Research Center. Psychosom Med 1995; 57: 138–147.
Carretero MD, Burgess AP, Soler P, Soler M, Catalan J. Reliability and validity of an HIV-specific health-related quality-of-life measure for use with injecting drug users. AIDS 1996; 10: 1699–1705.
O'Leary J, Ganz PA, Wu AW, Coscarelli A, Petersen L. Toward a better understanding of health-related quality of life: A comparison of the Medical Outcomes Study HIV Health Survey (MOS-HIV) and the HIV Overview of Problems-Evaluation System (HOPES). J Acquir Immune Defic Syndr Hum Retrovirol 1998; 17: 433–441.
Wu AW, Revicki DA, Jacobson D, Malitz FE. Evidence for reliability, validity and usefulness of the Medical Out-comes Study HIV Health Survey (MOS-HIV). Qual Life Res 1997; 6: 481–493.
Wu AW, Jacobson DL, Berzon RA, et al. The effect of mode of administration on medical outcomes study health ratings and EuroQol scores in AIDS. Qual Life Res 1997; 6: 3–10.
Wu AW, Jacobson D, Clark R, Revicki D, Scott-Lennox J, Feinberg J. Responsiveness of the EuroQol and MOS-HIV in advanced HIV disease. 5th Conference on Retrovirus and Opportunistic Infections 1998, Abstract.
Leplege A, Rude N, Ecosse E, Ceinos R, Dohin E, Pouchot J. Measuring quality of life from the point of view of HIV-positive subjects: The HIV-QL31. Qual Life Res 1997; 6: 585–594.
Holmes WC, Shea JA. Performance of a new, HIV/AIDS-targeted quality of life (HAT-QoL) instrument in asymptomatic seropositive individuals. Qual Life Res 1997; 6: 561–571.
Holmes WC, Shea JA. A new HIV/AIDS-targeted quality of life (HAT-QoL) instrument: Development, reliability, and validity. Med Care 1998; 36: 138–154.
Cella DF, McCain NL, Peterman AH, Mo F, Wolen D. Development and validation of the Functional Assessment of Human Immunodeficiency Virus Infection (FAHI) quality of life instrument. Qual Life Res 1996; 5: 450–463.
Peterman AH, Cella D, Mo F, McCain N. Psychometric validation of the revised Functional Assessment of Human Immunodeficiency Virus Infection (FAHI) quality of life instrument. Qual Life Res 1997; 6: 572–584.
Wu AW, Rubin HR, Mathews WC, et al. A health status questionnaire using 30 items from the Medical Outcomes Study. Preliminary validation in persons with early HIV infection. Med Care 1991; 29: 786–798.
Revicki DA, Sorensen S, Wu AW. Reliability and validity of physical and mental health summary scores from the medical outcomes study HIV health survey. Med Care 1998; 36: 126–137.
Lubeck DP, Fries JF. Assessment of quality of life in early stage HIV-infected persons: Data from the AIDS Time-oriented Health Outcome Study (ATHOS). Qual Life Res 1997; 6: 494–506.
Lubeck DP, Fries JF. Changes in quality of life among persons with HIV infection. Qual Life Res 1992; 1: 359–366.
Franchi D, Wenzel RP. Measuring health-related quality of life among patients infected with human immunodeficiency virus. Clin Infect Dis 1998; 26: 20–26.
Cunningham WE, Shapiro MF, Hays RD, et al. Constitutional symptoms and health-related quality of life in patients with symptomatic HIV disease. Am J Med 1998; 104: 129–136.
Murri R, Ammassari A, Fantoni M, et al. Disease-related factors associated with health-related quality of life in people with nonadvanced HIV disease assessed using an Italian version of the MOS-HIV Health Survey. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 16: 350–356.
De Boer JB, Sprangers MA, Aaronson NK, Lange JM, van Dam FS. A study of the reliability, validity and responsiveness of the HIV overview of problems evaluation system (HOPES) in assessing the quality of life of patients with AIDS and symptomatic HIV infection. Qual Life Res 1996; 5: 339–347.
Weinfurt KP, Willke RJ, Glick HA, Freimuth WW, Schulman KA. Relationship between CD4 count, viral burden, and quality of life over time in HIV-1-infected patients. Med Care 2000; 38: 404–410.
Badia X, Podzamczer D, Garcia M, Lopez-Lavid CC, Consiglio E. A randomized study comparing instruments for measuring health-related quality of life in HIV-infected patients. AIDS 1999; 13: 1727–1735.
Trust MO. How to score the SF-36 Short-Form Health Survey. Boston, MA: The Medical Outcomes Trust, 1992.
Ware JE, Sherbourne CD. The MOS 36 item short form health survey (SF-36): I. Conceptual framework and item selection. Med Care 1992; 30: 473–483.
Ware JE, Snow KK, Kosinski M, et al. SF-36 Health Survey: Manual and Interpretation Guide. Boston, MA: The Health Institute, New England Medical Center, 1993.
Ware JE, Kosinski M, Keller SD. SF-36 Physical and Mental Health Summary Scores: A User's Manual. Boston, MA: The Health Institute, New England Medical Center, 1994.
Burgess A, Dayer M, Catalan J, Hawkins D, Gazzard B. The reliability and validity of two HIV-specific health-re-lated quality-of-life measures: A preliminary analysis. AIDS 1993; 7: 1001–1008.
Frank L, Kleinman L, Leidy NK, Legro M, Shikiar R, Revicki D. Defining and measuring quality of life in medicine. JAMA 1998; 279: 429–430.
Lubeck DP, Fries JF. Health status among persons infected with human immunodeficiency virus. A community-based study. Med Care 1993; 31: 269–276.
PubMed Copyright information
© Kluwer Academic Publishers 2000